Sunovion taps Empatica for Phase 4 drug trial and two other digital health projects targeting epilepsy Posted on December 6, 2016 by timbatchelder Marlborough, Massachusetts-based pharma company Sunovion will use the Empatica Embrace, a wearable device for seizure detection, in a phase 4 clinical study of Aption, a drug meant to reduce seizures in people with epilepsy. Source: Sunovion taps Empatica for Phase 4 drug trial — and two other digital health projects targeting epilepsy | MobiHealthNews Share this:TwitterFacebookTumblrPinterestRedditWhatsAppEmailLinkedInPocketPrintLike this:Like Loading... Related Published by timbatchelder View all posts by timbatchelder